Korro Bio is trading 5.05% up now at $14.78 on September 16, 2026, with no confirmed catalyst identified.
- The latest identified company news was a September 11 inducement-grant filing.
- Biotech is declining, while major indexes are mixed to modestly higher; the gain does not clearly track broader market direction.
- The move may reflect trading-specific activity.